Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

CD34(+) cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicine.

Go back to Resources

CD34(+) cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicine.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Association between clinical risk factors and progression of chronic kidney disease in children.

Go back to Resources

Association between clinical risk factors and progression of chronic kidney disease in children.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.

Go back to Resources

Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Contemporary patterns of spontaneous labor with normal neonatal outcomes.

Go back to Resources

Contemporary patterns of spontaneous labor with normal neonatal outcomes.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

The Advanced Glaucoma Intervention Study: 8. Risk of cataract formation after trabeculectomy.

Go back to Resources

The Advanced Glaucoma Intervention Study: 8. Risk of cataract formation after trabeculectomy.

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma.

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma.

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Meeting highlights: a reappraisal of research results for the local treatment of early stage breast cancer.

Go back to Resources

Meeting highlights: a reappraisal of research results for the local treatment of early stage breast cancer.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Go back to Resources

Clinical trials referral resource. Current phase III, NCI-supported, Cooperative Group Clinical Trials in breast cancer.

Go back to Resources

Clinical trials referral resource. Current phase III, NCI-supported, Cooperative Group Clinical Trials in breast cancer.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Current cooperative group phase III clinical trials in early-stage breast cancer.

Go back to Resources

Clinical trials referral resource. Current cooperative group phase III clinical trials in early-stage breast cancer.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Health-Related Quality of Life in children with autism spectrum disorders: results from the autism treatment network.

Go back to Resources

Health-Related Quality of Life in children with autism spectrum disorders: results from the autism treatment network.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 57
  • Page 58
  • Page 59
  • Page 60
  • Current page 61
  • Page 62
  • Page 63
  • Page 64
  • Page 65
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification